Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersCod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasisGalectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor MicroenvironmentsNuclear transport of galectin-3 and its therapeutic implicationsGalectin-3 in angiogenesis and metastasis.Pleiotropy in complex traits: challenges and strategiesProteome-wide profiling of the MCF10AT breast cancer progression modelRacial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancerAutocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells.Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.Proteomic comparison of mcf-7 tumoursphere and monolayer culturesThe oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.Galectin-3: a potential target for cancer prevention.Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer CellsGalectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemiaAlteration of galectin-3 in tears of patients with dry eye diseaseInhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancerGalectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.Galectin-3 as a Potential Target to Prevent Cancer Metastasis.Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.Galectin-3: a possible complementary marker to the PSA blood testRegulation of prostate cancer progression by galectin-3Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.Galectins as cancer biomarkers.Extracellular galectin-3 in tumor progression and metastasis.Galectin-3 inhibitors: a patent review (2008-present).Biological applications of a chimeric probe for the assessment of galectin-3 ligands.Molecular basis of interaction between NG2 proteoglycan and galectin-3.Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis.RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.Regulation of tumor progression by extracellular galectin-3.Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer.Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain.
P2860
Q21134996-5E3B2331-A46E-4EE9-87DC-5D211B93115FQ24597542-17F9A8DC-422D-407B-8978-7FE277F94BB3Q26744513-DFC84338-8B9F-430C-A574-5D2304310A26Q26824889-14F1657B-F01E-4234-AC21-C2C822CC3FCCQ27687444-AB58683F-C7DB-4082-BED9-DF1DFD1B3868Q28390545-9DB3E524-EF41-44A3-A88A-ADC6DE414248Q28474333-71FD8DD7-EB60-448E-ABDE-C0A21DBA469CQ30494804-9B8EBB61-E0FE-4D0C-8D38-AE237D2F14E4Q30896248-A5490D3C-35C4-4687-BBE0-3AD616F69C10Q34056427-C6963628-8BEE-4A1B-B4AE-FF607F7950A1Q34318275-7189CBA6-7C5B-48D1-914F-995DB3943400Q34474679-F523EFAF-E11D-4F3F-B2EA-D9784D96DC50Q34534423-37B9D059-39DA-4294-8DBA-CA8D8A810ECFQ34622638-646B9556-76F1-4670-8439-5EFEB21880DDQ34626339-E70BADC4-40F2-4B7A-AA3F-CAAEEBE9A119Q34793403-FEDAF0D8-42E7-4807-9418-E7721E657B63Q35409569-20674485-9B73-431F-BA19-D811D231235EQ35589468-10869315-6A74-4723-96AC-8111B88DA52FQ35763903-E733082F-6D78-437F-A2FB-4481F49798CBQ35908448-88649394-01E6-44A0-A42A-ADE53FB44B12Q35945071-64784B50-1DA5-46C7-8C84-6597EF90A53DQ35995952-EB817962-3F06-466A-9C46-7D4A66596361Q36208118-0C7CD3BC-55C5-49B1-BBDC-7CB0A71EBEA1Q36326176-823083A7-FD60-41C2-9DAC-9092CCB13F98Q36733651-884EDDFE-C6AA-4451-80B7-8711BE42F575Q37038393-18DDC7DB-8E5F-44E3-A9F3-2A62AC67EED6Q37164578-010145C4-DF6A-4237-9367-027B27E54C9FQ37299331-F98A5D11-0B8E-4905-83B9-D0B93F84418FQ38105320-A13944A9-ED77-4C96-8AED-D3AA40188276Q38225141-EEA5DEE4-A89A-4BB7-9ED1-A26996482905Q38238525-86FD07CF-2D42-4FF3-B900-90E4E7D61D4FQ38300891-F2FE60FC-F03F-4C49-8FEF-45F47685B471Q38317537-4A5E1516-1A90-42BD-8421-1F406BDE341FQ38983451-765806CB-ABC3-4B58-9AA1-7CC855325AB9Q39805251-F9C0D77A-37E2-43BF-A1F7-77CEC617BF09Q39914225-D6052DEA-6CB3-43DD-AC81-C37D98AC7008Q42003225-93E60D1B-1C78-41D8-B402-1A95A57A9EDCQ43164816-9740AE1A-BC25-4B24-81BC-1E9D59EA9BDCQ43559327-5FF30A20-0823-4077-B4CF-FD4EB9BF888BQ49149324-A64F7A39-2567-46DC-8D8D-319F4AF0FAF7
P2860
Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@ast
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@en
type
label
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@ast
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@en
prefLabel
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@ast
Alterations in galectin-3 expr ...... lial-endothelial interactions.
@en
P2093
P2860
P1476
Alterations in galectin-3 expr ...... elial-endothelial interactions
@en
P2093
Avraham Raz
Fred Miller
Larry Tait
Malathy P V Shekhar
P2860
P304
P356
10.1016/S0002-9440(10)63245-2
P407
P577
2004-12-01T00:00:00Z